Meeting
2020 Genitourinary Cancers Symposium
Stereotactic body radiation therapy with androgen deprivation therapy for unfavorable-risk prostate cancer.
Authors
Sagar Anil Patel
Winship Cancer Institute of Emory University, Atlanta, GA
Sagar Anil Patel , Jeffrey M. Switchenko , Chao Zhang , Brent Shane Rose , Benjamin Walker Fischer-Valuck , Ashesh B. Jani , Ronald C. Chen , Trevor Joseph Royce
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Prostate Cancer
Track
Prostate Cancer - Advanced,Prostate Cancer - Localized
Sub Track
Therapeutics
Citation
J Clin Oncol 38, 2020 (suppl 6; abstr 332)
Abstract #
332
Poster Bd #
M16
Abstract Disclosures
Similar Posters
Poster
2018 ASCO Annual Meeting
Long-term androgen deprivation, with or without radiotherapy, in locally-advanced prostate cancer: Updated results from a phase III randomized trial.
First Author: Paul Sargos
Poster
2018 Genitourinary Cancers Symposium
Androgen deprivation therapy and overall survival for Gleason 8 versus Gleason 9-10 prostate cancer.
First Author: David Dewei Yang
Poster
2016 Genitourinary Cancers Symposium
Does the choice of hormone therapy affect medium-term outcomes following radical external beam radiotherapy for localized prostate cancer?
First Author: Ciara Lyons
Poster
2015 Genitourinary Cancers Symposium
Young age to predict for transient elevation in PSA after definitive stereotactic body radiation therapy for prostate cancer.
First Author: Seth Blacksburg